跳至主要内容
临床试验/NCT04500522
NCT04500522已完成4 期

Vaginal Isonicotinic Acid Hydrazide (INH) Prior to Diagnostic Office Hysteroscopy in Primarily Infertile Patients: a Randomized Controlled Trial

Aswan University Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2020年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
150
试验地点
1
主要终点
The difference in pain scores

研究概览

简要总结

To compare the effectiveness of vaginal isonicotinic acid hydrazide with placebo in minimizing the pain experienced by primarily infertile patients during diagnostic office hysteroscopy and to assess the ease of insertion of hysteroscope as reported by the hysteroscopist.

详细描述

hysteroscopy is commonly used in the diagnosis and treatment of intrauterine lesions such as polyps, fibroids, septa, and adhesions, and in the presence of abnormal bleeding and during the removal of an intrauterine device or foreign body. Cervical ripening is made possible by the use of medication through different routes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

double blind randomized controlled trial

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • nulliparous women with primary infertility requiring a diagnostic hysteroscopy as a part of an infertility diagnosis workup

排除标准

  • women with suspected pregnancy
  • heavy vaginal bleeding
  • recent pelvic infection
  • those known to have hypersensitivity or contraindication to isonicotinic acid hydrazide
  • those who received analgesics prior to office heavy vaginal bleeding
  • recent pelvic infection
  • a concomitant neurologic disease that could affect the correct evaluation of pain

研究组 & 干预措施

INH

Experimental

3 vaginal tablet of isonicotinic acid hydrazide (INH) 900 mg inserted by the patient 12 hours before the scheduled office hysteroscopy.

干预措施: INH (Drug)

Placebo Comparator

Placebo Comparator

3 vaginal tablet of Placebo inserted by the patient 12 hours before the scheduled office hysteroscopy.

干预措施: Placebo (Drug)

结局指标

主要结局

The difference in pain scores

时间窗: 10 minutes

Pain intensity will be assessed by visual analogue scale during the procedure. visual analogue scale ranging from 0 to 10

次要结局

  • Operative time(15 minutes)
  • Intensity of pain(30 minutes after the procedure)

研究者

发起方
Aswan University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

hany farouk

A Professor

Aswan University Hospital

研究点 (1)

Loading locations...

相似试验

Vaginal Isonicotinic Acid Hydrazide Prior to... | 临床试验